Come along to the Shares and AJ Bell Investor Evening in London on 20 June 2018 and listen to and meet Directors of listed companies. The event gives you the chance to come along and meet the key people at companies you might like to invest in. That counts for a lot. You get to speak to business leaders and company insiders face to face…
You get to find out how their business is doing... what challenges they may be facing... and what they’re going to do to give them the best chance of giving you a decent return on your investment. It’s a brilliant chance to get a far better picture of your potential investments.
Crusader Resources (CAS) - Crusader Resources Limited is a specialised minerals exploration company focussed on advancing its wholly owned core gold projects in Brazil across the project exploration and development curve. Over 130,000 metres of drilling has been completed over these projects, with almost 3 million ounces of resources discovered, 2.4 million ounces at Borborema, a key project in the group. An open pit gold project with strong economics, the Company is focussed on advancing Borborema through BFS and towards a construction decision. Diversity and exciting prospectivity comes from our Juruena and Nova Astro assets, where there is potential to identify economic and significant ore bodies in a gold district that is attracting interest from major mining companies.
Impax Asset Management (IPX) - Impax is a specialist asset manager, experienced at investing in the opportunities arising from the transition to a more sustainable global economy. Founded in 1998, Impax offers a range of thematic and unconstrained global equity strategies as well as real asset funds focused on the growth opportunity arising from a sustainable economy. They are engaged investors, in regular dialogue with companies in our portfolios and reporting on our stewardship activities to our clients. Where possible, they report on the positive environmental impact of their thematic investments; this positive impact is an outcome of their investment style.
SkinBioTherapeutics (SBTX) - SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester. The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company has shown that the SkinBiotix platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept.
Touchstone Exploration (TXP) - Touchstone Exploration Inc. is a UK listed but Canadian-based, international upstream oil and gas company currently active in the Republic of Trinidad and Tobago. It is one of the largest independent onshore oil producers in Trinidad, with an experienced management and executive team that have a track record of delivering value to shareholders. In Trinidad, the Company’s interests in approximately 90,000 gross acres of exploration and development rights make it one of the largest independent onshore oil producers in Trinidad. Touchstone holds over 8,700 working interest acres of onshore producing properties that have known crude oil reserves as well as over 55,000 exploration and undeveloped working interest acres that are being evaluated.
Who Should Attend
The evening is a perfect opportunity for existing shareholders or potential investors to hear from those that matter, the directors running the companies and fund managers managing their fund. Who better to explain the future potential and strategy.
Registration and coffee
Marcus Engelbrecht, MD - Crusader Resources (CAS)
Ian Simm, Founder & Chief Executive - Impax Asset Management Group (IPX)
Dr. Catherine O'Neill, CEO - SkinBioTherapeutics (SBTX)